Blunt cerebrovascular injuries in severe traumatic brain injury: incidence, risk factors, and evolution
Search for other papers by Pierre Esnault in
Current site
Google Scholar
PubMed
Search for other papers by Mickaël Cardinale in
Current site
Google Scholar
PubMed
Search for other papers by Henry Boret in
Current site
Google Scholar
PubMed
Search for other papers by Erwan D'Aranda in
Current site
Google Scholar
PubMed
Search for other papers by Ambroise Montcriol in
Current site
Google Scholar
PubMed
Search for other papers by Julien Bordes in
Current site
Google Scholar
PubMed
Search for other papers by Bertrand Prunet in
Current site
Google Scholar
PubMed
Search for other papers by Christophe Joubert in
Current site
Google Scholar
PubMed
French Military Health Service Academy Unit, École du Val-de-Grâce, Paris, France
Search for other papers by Arnaud Dagain in
Current site
Google Scholar
PubMed
Search for other papers by Philippe Goutorbe in
Current site
Google Scholar
PubMed
French Military Health Service Academy Unit, École du Val-de-Grâce, Paris, France
Search for other papers by Eric Kaiser in
Current site
Google Scholar
PubMed
French Military Health Service Academy Unit, École du Val-de-Grâce, Paris, France
Search for other papers by Eric Meaudre in
Current site
Google Scholar
PubMed
OBJECTIVE
Blunt cerebrovascular injuries (BCVIs) affect approximately 1% of patients with blunt trauma. An antithrombotic or anticoagulation therapy is recommended to prevent the occurrence or recurrence of neurovascular events. This treatment has to be carefully considered after severe traumatic brain injury (TBI), due to the risk of intracranial hemorrhage expansion. Thus, the physician in charge of the patient is confronted with a hemorrhagic and ischemic risk. The main objective of this study was to determine the incidence of BCVI after severe TBI.
METHODS
The authors conducted a prospective, observational, single-center study including all patients with severe TBI admitted in the trauma center. Diagnosis of BCVI was performed using a 64-channel multidetector CT. Characteristics of the patients, CT scan results, and outcomes were collected. A multivariate logistic regression model was developed to determine the risk factors of BCVI. Patients in whom BCVI was diagnosed were treated with systemic anticoagulation.
RESULTS
In total, 228 patients with severe TBI who were treated over a period of 7 years were included. The incidence of BCVI was 9.2%. The main risk factors were as follows: motorcycle crash (OR 8.2, 95% CI 1.9–34.8), fracture involving the carotid canal (OR 11.7, 95% CI 1.7–80.9), cervical spine injury (OR 13.5, 95% CI 3.1–59.4), thoracic trauma (OR 7.3, 95% CI 1.1–51.2), and hepatic lesion (OR 13.3, 95% CI 2.1–84.5). Among survivors, 82% of patients with BCVI received systemic anticoagulation therapy, beginning at a median of Day 1.5. The overall stroke rate was 19%. One patient had an intracranial hemorrhagic complication.
CONCLUSIONS
Blunt cerebrovascular injuries are frequent after severe TBI (incidence 9.2%). The main risk factors are high-velocity lesions and injuries near cervical arteries.
ABBREVIATIONS
BCVI = blunt cerebrovascular injury; CAI = carotid artery injury; CTA = CT angiography; DSA = digital subtraction angiography; GCS = Glasgow Coma Scale; GOS = Glasgow Outcome Scale; ICH = intracranial hemorrhage; ICP = intracranial pressure; IQR = interquartile range; ISS = Injury Severity Score; LMWH = low-molecular-weight heparin; ROC = receiver operating characteristic; TBI = traumatic brain injury; VAI = vertebral artery injury.
© Copyright 1944-2024 American Association of Neurological Surgeons